Clinicopathological features and treatment sensitivity of elderly Chinese breast cancer patients

Por LI, JUN-JIE, YU, KE-DA, DI, GEN-HONG, SHAO, ZHI-MIN
Publicado em 2010

Clinicopathologic characteristics at diagnosis and the survival of patients with medullary breast carcinoma in China: a comparison with infiltrating ductal carcinoma-not otherwise...

Por Cao, A-Yong, He, Min, Huang, Liang, Shao, Zhi-Ming, Di, Gen-Hong
Publicado em 2013

A Nomogram for Predicting the Pathological Response of Axillary Lymph Node Metastasis in Breast Cancer Patients

Por Jin, Xi, Jiang, Yi-Zhou, Chen, Sheng, Shao, Zhi-Ming, Di, Gen-Hong
Publicado no Sci Rep (2016)

The Effect of Laterality and Primary Tumor Site on Cancer-Specific Mortality in Breast Cancer: A SEER Population-Based Study

Por Bao, Jing, Yu, Ke-Da, Jiang, Yi-Zhou, Shao, Zhi-Ming, Di, Gen-Hong
Publicado em 2014

Prognostic value of receptor conversion after neoadjuvant chemotherapy in breast cancer patients: a prospective observational study

Por Jin, Xi, Jiang, Yi-Zhou, Chen, Sheng, Yu, Ke-Da, Shao, Zhi-Ming, Di, Gen-Hong
Publicado no Oncotarget (2015)

MicroRNA-200a confers chemoresistance by antagonizing TP53INP1 and YAP1 in human breast cancer

Por Yu, San-Jian, Yang, Liu, Hong, Qi, Kuang, Xia-Ying, Di, Gen-Hong, Shao, Zhi-Ming
Publicado no BMC Cancer (2018)

Estrogen Receptor (ER) β or p53 Attenuates ERα-mediated Transcriptional Activation on the BRCA2 Promoter

Por Jin, Wei, Chen, Ying, Di, Gen-hong, Miron, Penelope, Hou, Yi-feng, Gao, Hui, Shao, Zhi-ming
Publicado em 2008

A Straightforward but Not Piecewise Relationship between Age and Lymph Node Status in Chinese Breast Cancer Patients

Por Yu, Ke-Da, Li, Jun-Jie, Di, Gen-Hong, Wu, Jiong, Shen, Zhen-Zhou, Shao, Zhi-Ming
Publicado em 2010

Luminal B subtype: A key factor for the worse prognosis of young breast cancer patients in China

Por Tang, Li-Chen, Jin, Xi, Yang, Hai-Yuan, He, Min, Chang, Helena, Shao, Zhi-Ming, Di, Gen-Hong
Publicado no BMC Cancer (2015)

Pathological complete response as a surrogate for relapse-free survival in patients with triple negative breast cancer after neoadjuvant chemotherapy

Por Li, JunJie, Chen, Sheng, Chen, CanMing, Di, GenHong, Liu, GuangYu, Wu, Jiong, Shao, ZhiMin
Publicado no Oncotarget (2016)

Clinicopathological characteristics and treatment outcomes of occult breast cancer: a SEER population-based study

Por Ge, Li-Ping, Liu, Xi-Yu, Xiao, Yi, Gou, Zong-Chao, Zhao, Shen, Jiang, Yi-Zhou, Di, Gen-Hong
Publicado no Cancer Manag Res (2018)

A nomogram for predicting pathological complete response in patients with human epidermal growth factor receptor 2 negative breast cancer

Por Jin, Xi, Jiang, Yi-Zhou, Chen, Sheng, Yu, Ke-Da, Ma, Ding, Sun, Wei, Shao, Zhi-Min, Di, Gen-Hong
Publicado no BMC Cancer (2016)

Influence of a family history of breast and/or ovarian cancer on breast cancer outcomes

Por CAO, A-YONG, HE, MIN, DI, GEN-HONG, WU, JIONG, LU, JIN-SONG, LIU, GUANG-YU, SHEN, ZHEN-ZHOU, SHAO, ZHI-MING
Publicado em 2011

Tumor characteristics and the clinical outcome of invasive lobular carcinoma compared to infiltrating ductal carcinoma in a Chinese population

Por Cao, A-Yong, Huang, Liang, Wu, Jiong, Lu, Jin-Song, Liu, Guang-Yu, Shen, Zhen-Zhou, Shao, Zhi-Ming, Di, Gen-Hong
Publicado em 2012

The lymph node ratio as an independent prognostic factor for node-positive triple-negative breast cancer

Por He, Min, Zhang, Jia-Xin, Jiang, Yi-Zhou, Chen, Ying-Le, Yang, Hai-Yuan, Tang, Li-Chen, Shao, Zhi-Ming, Di, Gen-Hong
Publicado no Oncotarget (2017)

Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer

Por Yang, Hai-Yuan, Ma, Ding, Liu, Yi-Rong, Hu, Xin, Zhang, Jian, Wang, Zhong-Hua, Di, Gen-Hong, Hu, Xi-Chun, Shao, Zhi-Ming
Publicado no Sci Rep (2017)

Author Correction: Impact of hormone receptor status and distant recurrence-free interval on survival benefits from trastuzumab in HER2-positive metastatic breast cancer

Por Yang, Hai-Yuan, Ma, Ding, Liu, Yi-Rong, Hu, Xin, Zhang, Jian, Wang, Zhong-Hua, Di, Gen-Hong, Hu, Xi-Chun, Shao, Zhi-Ming
Publicado no Sci Rep (2018)

Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer

Por Chang, Xin-Zhong, Li, Da-Qiang, Hou, Yi-Feng, Wu, Jiong, Lu, Jin-Song, Di, Gen-Hong, Jin, Wei, Ou, Zhou-Luo, Shen, Zhen-Zhou, Shao, Zhi-Ming
Publicado em 2007

Correction to: Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer

Por Chang, Xin-Zhong, Li, Da-Qiang, Hou, Yi-Feng, Wu, Jiong, Lu, Jin-Song, Di, Gen-Hong, Jin, Wei, Ou, Zhou-Luo, Shen, Zhen-Zhou, Shao, Zhi-Ming
Publicado no Breast Cancer Res (2018)

ER-Poor and HER2-Positive: A Potential Subtype of Breast Cancer to Avoid Axillary Dissection in Node Positive Patients after Neoadjuvant Chemo-Trastuzumab Therapy

Por Li, Jian-wei, Mo, Miao, Yu, Ke-da, Chen, Can-ming, Hu, Zhen, Hou, Yi-feng, Di, Gen-hong, Wu, Jiong, Shen, Zhen-zhou, Shao, Zhi-ming, Liu, Guang-yu
Publicado no PLoS One (2014)